Jenny Prange

Jenny Prange serves as Chief Technology Officer at MUVON Therapeutics AG. MUVON Therapeutics AG operates in the research sector with approximately 24.0 employees. The company is headquartered in Schlieren, Zurich.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 1,552 executive contacts are available in Zurich.
• • Our database includes 201,469 c suite-level executives.

Google Cloud Hosting Outlook Microsoft Office 365 YouTube Mobile Friendly Wix Varnish Remote AI

biotechnology research muscle regeneration skeletal muscle therapy autologous cells muscle precursor cells stress urinary incontinence tissue engineering regenerative medicine biotechnology clinical trials phase ii study personalized treatment injury recovery functional restoration female health health span extension cell therapy biopsy procedure quality control gmp compliance muscle fiber formation non-invasive treatment patient-centered care sphincter muscle regeneration regeneration technology chronic disease treatment medical innovation cell expansion urinary incontinence solutions biomedical research university spin-off clinical stage therapeutics therapy development healthcare disruption human health improvement injectable therapy counseling support debilitating conditions research collaboration therapeutic platforms fda approval european partnerships patient empowerment cognitive health improvement age-related muscle loss medical advancements global health challenge treatment efficacy health care health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Jenny Prange in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at MUVON Therapeutics AG.

Jenny Prange's Position in the MessageCEO Database

• •Jenny Prange is 1 of 1 verified executive contact we track at MUVON Therapeutics AG.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •1,533 verified executive contacts in Zurich are in the database.
• •54 verified contacts work at research companies in the 24.0 employee range (same size as MUVON Therapeutics AG).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.

How do I reach Jenny Prange directly?

Jenny Prange's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at MUVON Therapeutics AG. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Jenny Prange work for?

Jenny Prange is Chief Technology Officer at MUVON Therapeutics AG, a company in the research sector with 24.0 employees. The company is based in Schlieren, Zurich.

Can I pitch or sell to Jenny Prange?

As Chief Technology Officer at MUVON Therapeutics AG, Jenny Prange is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Jenny Prange directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Jenny Prange in?

Jenny Prange works in the research industry as Chief Technology Officer at MUVON Therapeutics AG. MessageCEO provides verified contact information for executives across all major industries.

Is Jenny Prange's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Jenny Prange's profile is kept up-to-date with the latest available information.

Last updated: May 31, 2026